Verano HoldingsVRNOD +0.19%65 Days Inventory is 194.51 as of Mar. 2026, which is 54% above its 10-year median of 126.24. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $7.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 919 Drug Manufacturers companies, Verano Holdings ranks worse than 63.22% on this metric.
The historical rank and industry rank for Verano Holdings's Days Inventory or its related term are showing as below:
VRNOD'
s Days Inventory Range Over the Past 10 Years
Min: 118.82 Med: 126.24 Max: 197.32
Current: 197.32
During the past 7 years, Verano Holdings's highest Days Inventory was 197.32. The lowest was 118.82. And the median was 126.24.
VRNOD's Days Inventory is ranked worse than 63.22% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.44
vs VRNOD: 197.32
Verano Holdings's Days Inventory
increased
from Mar. 2025 (155.93) to Mar. 2026 (194.51).
It might indicate that Verano Holdings's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Verano Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Verano Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.12.
Verano Holdings (OTCPK:VRNOD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Verano Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Verano Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Verano Holdings Days Inventory Related Terms
Verano Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Verano Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Verano Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (VRNOD) has a Days Inventory of 194.51 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Verano Holdings and its competitors. This is 54% above median its historical median of 126.24. Over the past decade, Verano Holdings' Days Inventory has ranged from 118.82 to 197.32. According to the industry distribution chart, Verano Holdings ranks #581 out of 919 companies in the Drug Manufacturers industry, placing it in the top 63.2%.
Is Verano Holdings' Days Inventory too high?
Verano Holdings' current Days Inventory of 194.51 is 54% above median its 10-year median of 126.24. Over the past 10 years, this metric has ranged from a low of 118.82 to a high of 197.32. The Drug Manufacturers industry median Days Inventory is 162.44. Verano Holdings' value of 194.51 is 19.7% above this industry median. Based on the distribution chart, Verano Holdings ranks #581 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #581 out of 919 companies for Days Inventory. This places Verano Holdings in the lower half of its industry. The industry median Days Inventory is 162.44. Verano Holdings' value of 194.51 is 19.7% above this benchmark. Historically, Verano Holdings' own Days Inventory has ranged from 118.82 to 197.32 over the past decade. While the company's 10-year median is 126.24 vs. the industry median of 162.44, Verano Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.44, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current Days Inventory of 194.51 is 19.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current Days Inventory is 194.51, which is 54% above median its own 10-year median of 126.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current Days Inventory is 194.51, which is 54% above median its 10-year median of 126.24 and 19.7% above the Drug Manufacturers industry median of 162.44. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current Days Inventory is 194.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (VRNOD) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76.
GuruFocus considers Verano Holdings to be Possible Value Trap.
Key valuation signals for VRNOD:
Days Inventory: 194.51 (54% above median its 10-year median of 126.24)
GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
Industry Position: 19.7% above the Drug Manufacturers median (#581 of 919)
No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score
Get the complete analysis for VRNOD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRNOD has been successfully added to your 
